Radiation Oncology Home Page

 

General InformationClinical ResearchMedical PhysicsRadiation BiologyResidency ProgramDepartment FacultyDepartment HighlightsDepartment Newsletter

 

depfac_bio.gif (2178 bytes)

George Iliakis, Ph.D.
Professor, Radiation Oncology, Jefferson Medical College, Thomas Jefferson University Hospital

E-mail: george.iliakis@mail.tju.edu

Dr. Iliakis is a trained Radiobiologist. He received his Ph.D. in Biophysics from the University of Frankfurt/Main, Germany and is conducting research in United States since 1983. He is a recipient of the twentieth Radiation Research Society Research Award.

Dr. Iliakis is currently Professor and Associate Director of the Division of Experimental Radiation Oncology in the Department of Radiation Oncology of Thomas Jefferson University. He has served as Associate Editor for Radiation Research and the International Journal of Radiation Biology, and is presently Associate Editor for Radiation and Environmental Biophysics. Dr. Iliakis is the President of the Philadelphia Cancer Research Association. He is a member of the NCI Man Power study section that reviews training grant applications and has served as an ad hoc reviewer in numerous other study sections. He is a member of several Professional Societies including the American Society for the Advancement of Science, the Radiation Research Society, the American Association for Cancer Research, the North American Hyperthermia Society, and the European Society of Radiation Oncology. Dr. Iliakis also serves on committees of the Radiation Therapy Oncology Group.

Research in Dr. Iliakis' laboratory has a basic and a translational component. The basic research component focuses on the elucidation of the DNA damage response with emphasis on the mechanism of activation of the S-phase checkpoint as well the enzymology and regulation of non-homologous recombination. Translational research in Dr. Iliakis' laboratory focuses on the evaluation of interactions between drugs and radiation and the development and application of predictive assays in cancer therapy. Research in Dr. Iliakis' laboratory is funded by grants from the NCI, NASA, and Pharmaceutical Companies. Dr. Iliakis has authored or co-authored over 100 peer reviewed papers.

DNA Damage

Back to Department Faculty


Deparment Home Page | General Information | Clinical Research | Medical Physics | Radiation Biology | Residency Program |
Department Faculty | Department Highlights | Department News

smlog.gif (9272 bytes)

PLEASE NOTE:
The Kimmel Cancer Center Web site, its content and programs, is provided for informational and educational purposes only and is not intended as medical advice, nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.

Please send comments to: webmaster@lac.jci.tju.edu.
All contents copyright ©  2001 Thomas Jefferson University. All rights reserved.